Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 131,963	$ 15,483
Other current assets and prepaid expenses	3,124	7,386
Total current assets	135,087	22,869
Property and equipment, net	832	608
Right-of-use assets, net	504	575
Total assets	136,423	24,052
Current liabilities:
Accounts payable	10,120	10,138
Accrued expenses	20,058	18,645
Other current liabilities	1,372	1,835
Total current liabilities	31,550	30,618
Long-term liabilities
Other long term liabilities	400	107
Total long-term liabilities	400	107
Total liabilities	31,950	30,725
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 20,000,000 authorized and no shares issued or outstanding as of September 30, 2026 and December 31, 2025	0	0
Common stock, $0.0001 par value; 500,000,000 authorized as of September 30, 2026 and December 31, 2025, and 15,880,822 and 12,038,263 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively	1	1
Additional paid-in capital	819,290	599,249
Accumulated other comprehensive income	2,749	2,648
Accumulated deficit	(717,567)	(608,571)
Total stockholders’ equity	104,473	(6,673)
Total liabilities and stockholders’ equity	$ 136,423	$ 24,052